Premenstrual Syndromes : PMS and PMDD - Rutuja :: The site ...

17. Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence,
impairment, impact, and burden of premenstrual dysphoric disorder
(PMS/PMDD). Psychoneuroendocrinology 2003; 28: 1–23.
18. Pearlstein TB, Halbreich U, Batzar ED et al. Psychosocial functioning
in women with premenstrual dysphoric disorder before
and after treatment with sertraline or placebo. J Clin Psychiatry
2000; 61(2):101–9.
19. Murray CJL, Lopez AD, eds. The Global Burden of Disease: a
Comprehensive Assessment of Mortality and Disability from
Diseases, Injuries, and Risk Factors in 1990 and Projected to
2020. Boston: The Harvard School of Public Health, on behalf of
the World Health Organization and the World Bank; 1996.
20. Hylan TR, Sundell K, Judge R. The impact of premenstrual
symptomatology on functioning and treatment-seeking behavior:
experience from the United States, United Kingdom, and France.
J Womens Health Gend Based Med 1999; 8(8):1043–52.
21. Halbreich U. History and trajectory of PMS: towards a balanced
adaptation and a biosocial homeostasis. J Reprod Infant Psychol
2006; 24(4):1–11.
22. Jeliffe. New York State J Med (Report) 1906.
23. Frank RT. The hormonal causes of premenstrual tension. Arch
Neurol Psychiatry 1931; 26:1053.
24. Horney K. Die prämenstruellen Verstimmunugen. Zeitschrift für
psychonal Padagogiei 1931; 5:1–7.
25. Morton JH. Symposium on premenstrual tension. Int Record Med
1953; 166: 463–510.
26. WHO. International Classification of Diseases, 10th rev. Geneva:
World Health Organization; 1996.
27. American College of Obstetricians and Gynecologists (ACOG).
Premenstrual Syndrome. Washington, DC: ACOG; 2000.
28. Halbreich U, Endicott J. Relationship of dysphoric premenstrual
changes to depressive disorders. Acta Psychiatr Scand 1985;
71(4):331–8.
29. Halbreich U, Endicott J, Schacht S, Nee J. The diversity of premenstrual
changes as reflected in the Premenstrual Assessment
Form. Acta Psychiatr Scand 1982; 65(1):46–65.
30. Halbreich U. Menstrually related disorders: what we do
know, what we only believe that we know, and what we know
that we do not know. Crit Rev Neurobiol 1995; 9(2–3):163–75.
DIAGNOSIS OF PMS/PMDD 19
31. Halbreich U. Premenstrual dysphoric disorders: a diversified
cluster of vulnerability traits to depression. Acta Psychiatr Scand
1997; 95(3):169–76.
32. Halbreich U. Premenstrual syndromes. Ballière’s Clinical Psychiatry:
International Practice and Research: London: Ballière & Tindall;
1996; 2:667–86.
33. Halbreich U. Menstrually related changes and disorders: conceptualization
and diagnostic considerations. Neuropsychopharmacology
1993; 9(1):25–9.
34. Halbreich U, Alt IH, Paul L. Premenstrual changes. Impaired hormonal
homeostasis. Neurol Clin 1988; 6(1):173–94.
35. Halbreich U. The etiology, biology and evolving pathology of premenstrual
syndromes. Psychoneuroendocrinology 2003; 28:
55–99.
36. Halbreich U, Endicott J, Nee J. Premenstrual depressive changes.
Value of differentiation. Arch Gen Psychiatry 1983; 40(5):
535–42.
37. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual
dysphoric disorder – clinical procedures and research
perspectives. Gynecol Endocrinol 2004; 19:320–34.
38. Halbreich U, Endicott J. Methodological issues in studies of premenstrual
changes. Psychoneuroendocrinology 1985; 10(1):15–32.
39. Bloch M, Schmidt PJ, Rubinow DR. Premenstrual syndrome: evidence
for symptom stability across cycles. Am J Psychiatry 1997;
154(12):1741–6.
40. Halbreich U, Marshall-Hobika D, Garde J. Response rates to
selective serotonin reuptake inhibitors for treatment of premenstrual
dysphoric disorder. Proceedings of 2nd World Congress of
Women’s Mental Health, March 17–20. Washington, DC, 2004.
41. Halbreich U. Premenstrual syndromes: closing the 20th century
chapters. Curr Opin Obstet Gynecol 1999; 11:265–70.
42. Halbreich U. Menstrually related disorders – towards interdisciplinary
international diagnostic criteria. Cephalalgia 1997; 20(Suppl
17):1–4.
43. Halbreich U. Future directions for studies of women’s mental
health. Psychopharmacol Bull 1998; 34(3):327–31.
44. Halbreich U, Backstrom T, Eriksson E et al. Clinical diagnostic criteria
for PMS and guidelines for their quantification for research
studies. Gynecol Endocrinol 2007; 23(3): 123–30.